SOLESENCE, INC.
SLSNNasdaqConsumer Staples · Perfumes, Cosmetics & Other Toilet Preparations · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $62.1M | $52.3M | $37.3M | $37.3M | $29.5M | $17.1M |
| Operating income | $1.6M | $5.1M | −$3.5M | −$2.3M | $2.6M | $1.5M |
| Net income | $1.8M | $4.2M | −$4.4M | −$2.6M | $2.3M | $989,000 |
| Total assets | $50.1M | $50.0M | $32.9M | $33.6M | $28.4M | $13.5M |
| Total liabilities | — | — | — | — | — | — |
| Equity | $17.6M | $14.9M | $1.9M | $5.6M | $7.5M | $2.7M |
| EPS (diluted) | $0.02 | $0.07 | $-0.09 | $-0.05 | $0.05 | $0.03 |
| Shares out. | 70.1M | 54.8M | 49.5M | 48.9M | 38.2M | 38.1M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 2.5%
- Net margin
- 2.9%
- Return on equity
- 10.2%
- Return on assets
- 3.6%
- Return on capital (ROCE)
- 4.4%
- Liabilities / assets
- —
- Debt / equity
- —
- Book value / share
- $0.25
- Revenue growth (YoY)
- 18.6%
- Net income growth (YoY)
- −57.7%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Accruals / assets
- 20.7%high accruals
- Piotroski F-Score
- 3/8weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 2 warning● 2 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Negative operating cash flow
- High accruals — earnings-quality risk
- Operating margin is positive
- Revenue is growing year-over-year
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Aug 16, 2022
- NT 10-Kmissed a reporting deadline ↗Mar 29, 2019
- NT 10-Qmissed a reporting deadline ↗Nov 15, 2018
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Whitmore R JanetDirector | Dec 24, 2025 | Buy | 1,500 | $1.91 |
| Whitmore R JanetDirector | Nov 14, 2025 | Buy | 19,789 | $1.73 |
| Cureton KevinOfficer — Chief Operating Officer | Jun 5, 2025 | Option exercise | 4,693 | $0.42 |
| Whitmore Bradford T10% owner | May 29, 2025 | Buy | 2.5M | $4.20 |
| Whitmore R JanetDirector | Oct 29, 2024 | Buy | 2,000 | $0.90 |
| Cureton KevinOfficer — Chief Operating Officer | Sep 23, 2024 | Buy | 1,000 | $1.57 |
| Jankowski JessOfficer — President, CEO | Sep 24, 2024 | Option exercise | 81,000 | $0.44 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 801,431 | 20.4 | -0.8% |
| Apr 30, 2026 | 807,696 | 19.7 | -4.6% |
| Apr 15, 2026 | 846,495 | 15.8 | +17.8% |
| Mar 31, 2026 | 718,699 | 18.5 | -2.8% |
| Mar 13, 2026 | 739,381 | 27.5 | +6.4% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operationsMay 12, 2026
- Director / officer changeApr 29, 2026
- Results of operationsMar 31, 2026
- Director / officer changeDec 3, 2025
- Entered a material agreement · Director / officer changeDec 1, 2025
- Results of operationsNov 13, 2025
- Entered a material agreementNov 6, 2025
- Entered a material agreement · Director / officer changeSep 4, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 10-QQUARTERLY REPORTMay 12, 2026
- 8-KFORM 8-KMay 12, 2026
- 8-KFORM 8-KApr 29, 2026
- 10-K/AAMENDMENT TO FORM 10-KApr 23, 2026
- 10-KANNUAL REPORTMar 31, 2026
- 8-KFORM 8-KMar 31, 2026
- 4Dec 30, 2025
- 4Dec 11, 2025
- 8-KFORM 8-KDec 3, 2025
- 8-KFORM 8-KDec 1, 2025
- 8-KFORM 8-KNov 13, 2025
- 10-QQUARTERLY REPORTNov 12, 2025
- 8-KCURRENT REPORTNov 6, 2025
- 3Oct 6, 2025
- 8-KCURRENT REPORTSep 4, 2025
Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.